Latest Breaking News On - Dementia platform united kingdom - Page 1 : comparemela.com

Another Alzheimer s drug from US pharma giant Eli Lilly is expected to perform even better than donanemab, which was this week hailed as a breakthrough .

United kingdomUnited statesEli lillyAlois alzheimerIvan koychevGiles hardinghamGlori weissNational institute for healthOxford university dementia platform united kingdomUnited kingdom dementia research instituteAlzheimer associationNational instituteCare excellenceOxford universityDementia platform united kingdomAlzheimers disease